國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Estrogen receptor and breast cancerc...

SpringerLink (Online service)

Estrogen receptor and breast cancercelebrating the 60th anniversary of the discovery of ER /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Estrogen receptor and breast canceredited by Xiaoting Zhang.
其他題名:	celebrating the 60th anniversary of the discovery of ER /
其他作者:	Zhang, Xiaoting.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xii, 417 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	EstrogenReceptors.
電子資源:	https://doi.org/10.1007/978-3-319-99350-8
ISBN:	9783319993508$q(electronic bk.)

Estrogen receptor and breast cancercelebrating the 60th anniversary of the discovery of ER /
Estrogen receptor and breast cancercelebrating the 60th anniversary of the discovery of ER /[electronic resource] :edited by Xiaoting Zhang. - Cham :Springer International Publishing :2019. - xii, 417 p. :ill., digital ;24 cm. - Cancer drug discovery and development,2196-9906. - Cancer drug discovery and development..

1. Introduction: On the discovery of Estrogen Receptor -- 2. Physiological and Pathological Roles of Estrogen Receptor -- 3. Estrogen Receptor Cofactors -- 4. ER-Mediated Gene Transcription -- 5. ER Transcriptome -- 6. Estrogen Receptor Regulation of Non-Coding RNAs in Breast Cancer -- 7. First Targeted Therapy --- History of Tamoxifen -- 8. Selective Estrogen Receptor Modulators (SERMs) -- 9. New Estrogen Receptor Drugs -- 10. Endocrine Therapy in Clinical Practice -- 11. Structural Insights into ER and Anti-Estrogen Therapies -- 12. Molecular Mechanisms of Endocrine Resistance -- 13. Estrogen Receptor Mutants in Breast Cancer -- 14. Estrogen Receptor Beta and Isoforms in Breast Cancer -- 15. Xenoestrogens, Phytoestrogens and Breast Cancer -- 16. Emerging Approaches to Overcome Endocrine Resistance.

The discovery of ER by Dr. Elwood Jensen exactly 60 years ago has not only led to the birth of a whole new vital nuclear receptor research field but also made a rapid, direct and lasting impact on the treatment and prevention of breast cancer. Since that landmark discovery, tremendous progress has been made in our understanding of the molecular functions of ER and development of targeted therapies against ER pathways for breast cancer treatment. However, there is currently no book available addressing these discoveries and recent advancement in a historical and systematic fashion. This book is intended to provide comprehensive, most up-to-date information on the history and recent advancement of ER and breast cancer by world renowned leaders in the field. These chapters include the history of the discovery of ER; physiological and pathological roles of ER; recent discovery of ER cistrome, transcriptome and its regulation of noncoding RNAs such as microRNAs and enhancer RNAs in breast cancer; development and clinical practices of the first targeted therapy Tamoxifen and other antiestrogens for breast cancer treatment; structural basis of ER and antiestrogen actions; molecular insights into endocrine resistance; the role of ER mutants, ER-beta and environmental estrogens in breast cancer; and emerging state-of-the-art therapeutic approaches currently in development to overcome treatment resistance and future perspectives. The book will provide undergraduate and graduate students, basic scientists and clinical cancer researchers, residents, fellows, as well as clinicians, oncology educators and the general public a thorough and authoritative review of these exciting topics.

ISBN: 9783319993508$q(electronic bk.)

Standard No.: 10.1007/978-3-319-99350-8doiSubjects--Topical Terms:

834595
Estrogen
--Receptors.

LC Class. No.: QP572.E85 / E887 2019

Dewey Class. No.: 616.99449061

Estrogen receptor and breast cancercelebrating the 60th anniversary of the discovery of ER /
LDR:03586nmm a2200337 a 4500 001 553373
003 DE-He213
005 20190604101541.0
006 m d
007 cr nn 008maaau
008 191111s2019 gw s 0 eng d
020 $a 9783319993508$q(electronic bk.)
020 $a 9783319993492$q(paper)
024 7 $a 10.1007/978-3-319-99350-8 $2 doi
035 $a 978-3-319-99350-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QP572.E85 $b E887 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449061 $2 23
090 $a QP572.E85 $b E82 2019
245 1 0 $a Estrogen receptor and breast cancer $h [electronic resource] : $b celebrating the 60th anniversary of the discovery of ER / $c edited by Xiaoting Zhang.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2019.
300 $a xii, 417 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer drug discovery and development, $x 2196-9906
505 0 $a 1. Introduction: On the discovery of Estrogen Receptor -- 2. Physiological and Pathological Roles of Estrogen Receptor -- 3. Estrogen Receptor Cofactors -- 4. ER-Mediated Gene Transcription -- 5. ER Transcriptome -- 6. Estrogen Receptor Regulation of Non-Coding RNAs in Breast Cancer -- 7. First Targeted Therapy --- History of Tamoxifen -- 8. Selective Estrogen Receptor Modulators (SERMs) -- 9. New Estrogen Receptor Drugs -- 10. Endocrine Therapy in Clinical Practice -- 11. Structural Insights into ER and Anti-Estrogen Therapies -- 12. Molecular Mechanisms of Endocrine Resistance -- 13. Estrogen Receptor Mutants in Breast Cancer -- 14. Estrogen Receptor Beta and Isoforms in Breast Cancer -- 15. Xenoestrogens, Phytoestrogens and Breast Cancer -- 16. Emerging Approaches to Overcome Endocrine Resistance.
520 $a The discovery of ER by Dr. Elwood Jensen exactly 60 years ago has not only led to the birth of a whole new vital nuclear receptor research field but also made a rapid, direct and lasting impact on the treatment and prevention of breast cancer. Since that landmark discovery, tremendous progress has been made in our understanding of the molecular functions of ER and development of targeted therapies against ER pathways for breast cancer treatment. However, there is currently no book available addressing these discoveries and recent advancement in a historical and systematic fashion. This book is intended to provide comprehensive, most up-to-date information on the history and recent advancement of ER and breast cancer by world renowned leaders in the field. These chapters include the history of the discovery of ER; physiological and pathological roles of ER; recent discovery of ER cistrome, transcriptome and its regulation of noncoding RNAs such as microRNAs and enhancer RNAs in breast cancer; development and clinical practices of the first targeted therapy Tamoxifen and other antiestrogens for breast cancer treatment; structural basis of ER and antiestrogen actions; molecular insights into endocrine resistance; the role of ER mutants, ER-beta and environmental estrogens in breast cancer; and emerging state-of-the-art therapeutic approaches currently in development to overcome treatment resistance and future perspectives. The book will provide undergraduate and graduate students, basic scientists and clinical cancer researchers, residents, fellows, as well as clinicians, oncology educators and the general public a thorough and authoritative review of these exciting topics.
650 0 $a Estrogen $x Receptors. $3 834595
650 0 $a Estrogen $x Therapeutic use. $3 834596
650 0 $a Breast $x Cancer $x Hormone therapy. $3 484165
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Molecular Medicine. $3 273932
700 1 $a Zhang, Xiaoting. $3 834594
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer drug discovery and development. $3 557535
856 4 0 $u https://doi.org/10.1007/978-3-319-99350-8
950 $a Medicine (Springer-11650)